We are live on ! Find out more
ANGO icon

AngioDynamics

138 hedge funds and large institutions have $428M invested in AngioDynamics in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 43 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more call options, than puts

Call options by funds: $1.06M | Put options by funds: $340K

21% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 43

14% more capital invested

Capital invested by funds: $374M → $428M (+$53.9M)

2.34% less ownership

Funds ownership: 97.63%95.29% (-2.3%)

5% less funds holding

Funds holding: 146138 (-8)

28% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 25

Holders
138
Holders Change
-8
Holders Change %
-5.48%
% of All Funds
2.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
52
Reduced
43
Closed
25
Calls
$1.06M
Puts
$340K
Net Calls
+$723K
Net Calls Change
+$942K

ANGO Hedge Fund Activity: Q3 2020 in Review

138 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2020, worth a combined $428M — up 14% from $374M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ANGO and 18 opened new positions — a net loss of 7 holders — while 43 trimmed existing stakes and 52 added.

The largest buyer was Parian Global Management, opening a new position worth an estimated $3.29M. The largest seller was Tributary Capital Management, exiting entirely with an estimated $6.96M sold.

  • 138 institutional investors held AngioDynamics (ANGO) as of Q3 2020, down from 146 in Q2 2020.
  • Funds reported $428M of AngioDynamics stock for Q3 2020, up 14% quarter-over-quarter.
  • 18 funds opened new AngioDynamics positions in Q3 2020 and 25 closed out, a net change of -7 holders.
  • The largest AngioDynamics buyer in Q3 2020 was Parian Global Management, an estimated $3.29M added.
  • The largest AngioDynamics seller in Q3 2020 was Tributary Capital Management, an estimated $6.96M sold.

Based on aggregated 13F filings for Q3 2020.